Belzutifan

Embryo-Fetal Toxicity

  • Exposure to WELIREG during pregnancy can cause embryo-fetal harm.
  • Verify pregnancy status prior to the initiation of WELIREG.
  • Advise patients of these risks and the need for effective non-hormonal contraception. WELIREG can render some hormonal contraceptives ineffective

Patient counseling

Medical guidelines

Package inserts

Keywords: Welireg
Updated: September 2021